Breaking News, Promotions & Moves

Grail Inc. Announces CEO Transition

Josh Ofman to serve as CEO following Bob Ragusa’s retirement in June.

Author Image

By: Charlie Sternberg

Associate Editor

Healthcare company Grail Inc.’s Chief Executive Officer (CEO) Bob Ragusa will retire in June. The company’s current President, Josh Ofman, MD, MSHS, will serve as CEO upon Ragusa’s retirement. In addition, Ofman has been appointed to Grail’s Board of Directors, effective immediately. Ofman’s appointment is the culmination of a succession planning process to ensure leadership continuity and strategic execution. Ragusa will remain on Grail’s Board until June 1, 2026, and...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters